Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

InflaRx N.V. (IFRX)

NASDAQ
Currency in USD
Disclaimer
1.180
-0.020(-1.67%)
Closed
Pre Market
1.200+0.020(+1.69%)

IFRX Comments

😳😳😳 why is dropping instead of going up this B....SH 😤
are we do for a short squeeze is going up to fast
what just happened 😳 did someone just make a 1 million PUT on this or what why this drop can believe it
cross 5 we're gone
Trash
trash hahaha I hope you shorted this best of luck your going to need it!!!!!!!!
Interesting chart...
Totally undervalued and Q4 promises to be eventful. 1) Covid P3 trial results. 2) AAV P2 trial results. 3) Official funding from German government. 4) Final design of HS P3 study in collaboration with the FDA.
5
Wish it happens as soon as possible
Buyyyy 2.62
what is ur pt?
good stock at 3?
Getting out. They blew it. Atleast in the near term.
how about now?
Loading up again... 10+ coming
Its a buy again...
Boom!
Big popComin
Seeking Alpha claims InflaRx reports underwhelming data but Benzinga claims encouranging results. WTH.
Please release some news. Weve been hearing about covid trials for weeks!
you got what you asked for. They just released results.
I changed my mind! It was better without... :) but seriously, i think this sell off is overdone. If phase ll was poor (and i dont think it was) they wouldnt be continuing to phase lll
 exactly!
yeeeeea hot mama!
gooooo, underdog!
will IFRX be the secret underdog?
Acute pneumonia from old,Gawasaki-like symptoms from young.Both are caused by C5a complement.
Great stock. Worth keeping for at least 3 yrs
they are hiring a lot of medical personal, obviously company is expanding
Boom the moon
I'm pharmacy student. Take a good look at this company and their target. C5a has been a minor target of Anti-inflammation. But paradigm's gonna change after SARS Cov 2
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.